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ABSTRACT
Introduction: Ergonomic dialing torque may
enhance safety and comfort when setting doses
with insulin pens. Limited data are available on
the correlation of dialing torque and dialing
comfort.
Methods: Three studies were performed with
SoloSTAR (SS; Sanofi), FlexPen (FP; Novo
Nordisk), KwikPen (KP; Eli Lilly) and
FlexTouch (FT; Novo Nordisk) pens. Dialing
behavior was examined with 20 pen-
experienced people with diabetes. Participants
dialed up to the maximum dose and back down
to ‘‘zero’’ with each pen. Hand and pen
movements were recorded by video camera
and rotational speeds and angles calculated for
each pen. In a laboratory study, dialing torque
was measured discontinuously at a speed of
120/s, reflecting typical patient behavior.
Sixteen pen-experienced people with diabetes
participated in a pilot preference study. Using a
Likert scale, subjective dialing comfort rankings
and ratings were obtained for each pen type and
matched to their dialing torque. SS, FP, KP, and
FT1 were investigated at 0–20 U each and at
60–80 U for FT2.
Results: SS was ranked most comfortable for
up-dialing by 8 and down-dialing by 6 of the 16
participants, respectively; FP, 5 and 8; FT1, 2
and 1; and KP, 1 and 1. FT2 was ranked least
comfortable by 12 and 10 participants. Comfort
for up- and down-dialing was rated ‘‘very
comfortable’’ for SS by 15 participants each,
followed by FP (12 and 14), KP (10 each), and
FT1 (9 and 7); FT2 was rated ‘‘less’’ or ‘‘not’’
comfortable by 10 and 11 people, respectively.
Conclusion: In this pilot study, subjective
ratings of dialing comfort for different insulin
pens by participants appear to concur with
previous laboratory dialing torque study
results. There appears to be a ‘‘torque comfort
zone.’’ Torques above 50 N mm reduced
subjective handling comfort. Further, larger
scale studies are needed to establish that
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dialing torque affects pen users’
comfort.
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INTRODUCTION
The use of injection devices has become more
popular for patients with type 1 or type 2
diabetes mellitus who require insulin
injections. The main advantages these
devices have over traditional vial and
syringes are their ease of use and
convenience [1–4]. The growing popularity of
insulin pen devices has led to a number of
studies on their usage. Certain technical
aspects of insulin pens—such as injection
force [5–9] and dose accuracy [4, 5, 7, 8, 10–
13]—are thoroughly studied, but there is a
paucity of data on the dialing torque required
for setting a dose.
Setting the dose is a vital step for people with
diabetes who regularly self-inject insulin. All
available insulin pen types require applying a
torque for dialing a dose. Dialing comfort is
influenced by dialing torque [14] and other
factors, such as size and shape of the dose
button. When turning dose buttons for
selecting a dose, the torque level should not
exceed a certain level from a human
engineering point of view. The recommended
torque for turning knobs with a diameter of
15–25 mm is 20–50 N mm [15]. For insulin
pens, the torque useful for proper dose setting
in clinical practice has been reported to be
10–30 N mm [16]; patient preferences and
behavior, however, have not been studied
until now.
Protocols used in recent laboratory torque
studies using continuous dose dialing at dialing
speeds of 1 U/s [16] are not based on real-life
conditions and may not reflect user experience.
With the aim to identify user preferences of
dialing torques under conditions as close to real
life as possible, three studies were performed: a
field study to identify real-life dialing behavior
of participants dialing a dose; a laboratory study
of dialing torques using common dialing
routines used by people with diabetes; and a
pilot study to investigate the impact of different
torque levels on perceived dialing comfort. All
three studies compared four commonly used
insulin pens: SoloSTAR (SS; Sanofi), FlexPen
(FP; Novo Nordisk), KwikPen (KP; Eli Lilly) and
FlexTouch (FT; Novo Nordisk).
METHODS
Compliance with Ethics Guidelines
All procedures followed were in accordance
with the Helsinki Declaration, as revised in
2013. Informed consent was obtained from all
patients for being included in the study.
Test Pens
Four disposable insulin pen types were tested:
SS, filled with insulin glulisine; FP and FT, filled
with insulin aspart; and KP, filled with insulin
lispro. The pens were fitted with needles
according to the manufacturers’ instructions.
Study Designs
The field study for the investigation of dialing
behavior was performed with 20 pen-
experienced people with diabetes [12 female, 8
male; mean (SD) age 55 ± 14 years; 5 with type
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1 diabetes, 15 with type 2; all without motor
impairment]. Participants dialed up to the
maximum dose and down from the maximum
dose to ‘‘zero’’ with each pen. Hand and pen
movements were recorded by a video camera at
25 frames per second. Rotational speeds and
angles were calculated from video data for each
pen.
The laboratory study evaluated dialing
torques of the four pens when dialing up to
the maximum dose and dialing down from the
maximum dose to ‘‘zero’’ [17]. Dialing torque
was measured discontinuously at a speed of
120/s, reflecting typical patient behavior as
determined by the field study; in addition,
torque was measured continuously at 1 U/s in
order to compare the results with published
data. Torque was measured with a Mecmesin
torque machine (Mecmesin Ltd, West Sussex,
UK) using an ITC Sensor with 1.5 N mm
sensitivity. The machine and torque sensor
were calibrated by the manufacturer prior to
the measurements. Dial torque was measured
for 20 pens of each pen type, with two
repetitions per pen.
The pilot preference study included 16 pen-
experienced people with type 2 diabetes (8
female, 8 male; mean (SD) age 60 ± 10 years;
no chronic motor impairments). Subjective
dialing comfort rankings and ratings were
obtained for each pen type and matched to
the same pen type tested in the laboratory
torque procedure. FT was used in two setups
(FT1: 0–20 U and FT2: 60–80 U) because of the
difference in dialing torque levels found in the
laboratory study [17]. The pens were randomly
presented and participants asked to up-dial
from 0 to 20 U and from 60 to 80 U for FT1
and FT2, respectively. Then the up-dialing
comfort of all pens was ranked by participants.
The procedure was repeated for down-dialing.
Comfort ratings were obtained after the ranking
for up- followed by down-dialing. Participants
answered the question ‘‘For me, the up-dialing/
the down-dialing of the pen is very
comfortable’’ using a Likert scale where 1 = I
absolutely agree; 2 = I agree; 3 = I rather agree;
4 = I rather disagree; 5 = I disagree; and 6 = I
absolutely disagree.
Statistical Analysis
Descriptive statistics (mean, SD) were calculated
for rotational speeds and angles. No inferential
statistics were conducted due to the small study
group. Differences between torque data were
calculated using the paired two-sample
Student’s t test. Differences between comfort
rankings were calculated with a Wilcoxon rank
sum test. The level of significance for all tests
was set to 5% (P = 0.05).
RESULTS
Dose Dialing Under Field Conditions
In contrast to laboratory procedures, people
dialed doses discontinuously with a pause of
0.3 ± 0.1 s between dialing intervals. The
measured angles were equivalent to
approximately 10 U per rotation and to
rotational speeds [13 U/s (Table 1). Mean
rotational angle for up- and down-dialing was
171 ± 44 and 190 ± 37, respectively; mean
rotational speed was 238 ± 87/s and
259 ± 99/s, respectively. Rotational angle and
rotational speed differed considerably for both
people and pen types.
Laboratory Determination of Dialing
Torque
The up-dialing torque was significantly greater
than the down-dialing torque for all pen types
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using discontinuous or continuous dialing at
1 U/s or 120/s, except for continuous dialing at
1 U/s with SS (Table 2). The difference in torque
between up-dialing and down-dialing was
greater for KP and FP than for SS and FT. Also,
torques differed when comparing continuous
versus discontinuous dialing, though not all
differences reached significance. The maximum
dialing torque depended strongly on the chosen
speed setting.
Regardless of the chosen speed, different pen
types required different dialing torques to dial a
maximum dose (Fig. 1). FP had the lowest
dialing torques, followed by SS, with
consistently lower dial-up torques than KP. FT
required up to seven times higher dial-up
torques than FP, due to its spring-loaded
mechanism. Maximum dial-up torques for
discontinuous dialing exceeded 80 N mm with
FT at 120/s (8 U/s).
















SoloStar 179 (47) 9.9 (2.6) 249 (89) 13.83 (4.96) 197 (43) 10.9 (2.4) 267 (96) 15.39 (5.36)
FlexPen 177 (47) 9.8 (2.6) 249 (107) 13.83 (5.93) 240 (38) 13.3(2.1) 303 (125) 16.83 (6.92)
FlexTouch 154 (42) 10.3 (2.8) 197 (71) 13.13 (4.70) 180 (33) 12.0 (2.2) 198 (79) 13.20 (5.30)
KwikPen 174 (41) 9.7 (2.3) 259 (81) 14.39 (4.51) 179 (35) 9.9 (1.9) 256 (76) 14.22 (4.21)
Values are mean (SD)
Table 2 Torque for discontinuous and continuous up- and down-dialing at rotational speeds of 1 U/s and 120/s with four
disposable pens
Pen Discontinuous dialing Continuous dialing
Up-dialing Down-dialing P value Up-dialing Down-dialing P value
At 1 U/s
SoloStar 17.37 (2.08) 14.78 (1.54) \0.001 15.91 (2.33) 15.17 (3.70) 0.287
FlexTouch 75.70 (9.35) 59.45 (10.73) \0.001 81.46 (14.74) 57.21 (9.70) \0.001
FlexPen 12.47 (1.81) 5.18 (0.67) \0.001 11.96 (3.51) 3.38 (3.25) \0.001
KwikPen 27.18 (6.47) 10.36 (6.88) \0.001 24.79 (4.97) 12.38 (4.69) \0.001
At 120/s
SoloStar 16.98 (2.33) 15.18 (1.66) \0.001 18.45 (5.43) 14.79 (6.03) 0.005
FlexTouch 81.80 (11.49) 60.66 (11.79) \0.001 86.43 (12.58) 72.90 (15.13) \0.001
FlexPen 14.23 (2.74) 6.41 (0.94) \0.001 14.60 (4.00) 4.03 (3.69) \0.001
KwikPen 23.34 (5.46) 12.60 (5.52) \0.001 22.64 (3.87) 12.35 (4.04) \0.001
Values are mean (SD) in N mm
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Additionally, torque variation patterns were
different for each pen type. The torque pattern
of FT for up-dialing was different from that of all
the other pens (Fig. 2). When dialing up or
down, maximum and mean torques were
constant for SS, FP, and KP during the dialing
process (cylinder shape). For FT, however,
torque for up-dialing increased significantly
(P\0.001) when dialing from zero to 80 U
(‘‘tornado’’ shape).
Assessment of Dialing Torque Comfort:
A Pilot Study
In a ranking that combined evaluation of the
comfort during up- and down-dialing, SS was
ranked best, being preferred by 8 participants
for up-dialing and by 6 participants for down-
dialing, followed by FP (5 for up, 8 for down-
dialing; Fig. 3a). FT1 was preferred by only 2
participants for up and 1 for down, while KP
Fig. 1 Comparison of maximum torque for discontinuous up-dialing at 1 U/s and 120/s in relation to dialing torque
recommendations by ISO [15] and Asakura [16]. P values were calculated with a paired two-sample t test
Fig. 2 Illustration of torque for discontinuous up-dialing at 120/s. Sample data of one test pen for each pen model
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was preferred by only 1 for up and 1 for down.
FT2 (dialing from 60 to 80 U and back) was not
rated best by any participant. The majority of
participants (12/16 for up-dialing and 10/16 for
down-dialing) rated FT2 the worst of all the
pens (Fig. 3b).
This sequence was confirmed by the results
using the Likert scale, where SS stood out with
15 participants rating it very comfortable for up-
as well as for down-dialing compared with 12
and 14, respectively, for FP; KP (10 for each) and
FT1 (9 and 7, respectively). FT2 was rated ‘‘less’’
or ‘‘not’’ comfortable by the majority of
participants (10 and 11, respectively).
DISCUSSION
This pilot study suggests a new basis for the
evaluation of dialing torque in commonly
available insulin injection pens by taking into
consideration the behavior of patients under
real-life conditions. With knowledge of how
people handle pens during a field study,
laboratory evaluation of dialing torque can be
performed with protocols that more closely
mimic real-life use. Comparison of these
dialing torque values with user rankings and
ratings from a preference study then can allow
for conclusions to be drawn about the clinical
Fig. 3 Distribution of rankings (a) and ratings (b) for up- and down-dialing with four disposable pens: a pilot study. FP
FlexPen, FT1 FlexTouch (dialing from 0 to 20 U), FT2 FlexTouch (dialing from 60 to 80 U), KP KwikPen, SS SoloSTAR
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relevance of dialing torque and about
appropriate torque values for future devices.
The results of this study suggest that
common laboratory procedures for dialing
insulin doses differ markedly from how they
are dialed by pen-experienced people with
diabetes. People dial doses discontinuously at
dialing speeds [13 U/s and at rotational angles
[10 U per rotation, with pauses of 0.3 ± 0.1 s
between dialing intervals, whereas laboratory
procedures employ continuous dose dialing at
slower dialing speeds.
Dialing speed had an impact on the
measured dialing torque for all tested pens,
but the effect differed between pens. For
example, up-dialing torque increased
significantly for FP and FT at the higher speed
of 120/s compared with 1 U/s (dialing
discontinuously), while for SS and KP it
decreased at the higher speed. Significant
differences between pens were also found for
dialing torque with discontinuous dose button
rotation. This was true using real-life dialing
behavior of pen-experienced people with
diabetes as well as other measurement
protocols [14]. Interestingly, torque for down-
dialing was found to be lower than for up-
dialing for all pen types. This is unusual in the
design of the torque course of small turning
knobs, but may increase comfort for patients
with visual or motor impairments. Further
studies would be beneficial to confirm the
effects of varying torques for up- and down-
dialing. These results show that people using
insulin pens encounter varying torque when
setting a dose. Thus, it is reasonable to use
dialing speeds and angles close to the real-life
dialing behavior of pen-experienced people
with diabetes for future studies on dialing
torques.
Results of the pilot comfort study suggest that
people may have a preference regarding dialing
torque (Fig. 4). The comfort of pens with high
dialing torque was ranked and rated very low,
suggesting that a torque exceeding 30 N mm [16]
decreased perceived dialing comfort while
torque levels of C50 N mm [15] appeared to
induce dialing discomfort. Surprisingly, the pen
with the lowest dialing torque (FP) was not rated
or ranked best during the study. This suggests
that either there is a comfort zone of dialing
torques for people or that other factors influence
Fig. 4 Relation of dialing torque and dialing comfort for
four disposable pens. Comfort rating was the total of best
and second best ratings in the pilot study. The gray zone
indicates the range up to 50 N mm as recommended by
ISO 894–3:201015; n = 16 patients. FP FlexPen, FT1
FlexTouch (dialing from 0 to 20 U), FT2 FlexTouch
(dialing from 60 to 80 U), KP KwikPen, SS SoloSTAR
Diabetes Ther (2015) 6:85–93 91
their choice. It also suggests that an appropriate
dialing torque might be a key feature of pen
handling: discomfort might lead to deficient
adherence to the therapy and consequently to
problems in glycemic control, especially given
the impaired manual dexterity of many people
with diabetes mellitus.
There are limitations to our studies. Since the
user studies performed were small in size and all
three studies were limited to the most common
pens, they might be biased and not fully mirror
peoples’ behavior. We also did not measure
dialing torque and evaluate user comfort
simultaneously, which might result in some
deviation of both parameters from the present
results. In addition, the study was not aimed at
differentiating between differences in up- and
down-dialing. Further, larger scale comfort
studies that are sufficiently powered will be
required to definitively provide proof of
concept that dial torque affects user comfort.
Nevertheless, the preferences shown in our pilot
study appear to emphasize the relevance of
dialing torque measurement for user comfort—
as well as the importance of considering all
tasks performed with pens, not just the act of
injection alone [8].
CONCLUSION
In this pilot study, subjective ratings of dialing
comfort for different insulin pens by
participants appear to agree with previous
laboratory dialing torque study results. There
appears to be a ‘‘torque comfort zone’’. Lowest
dialing torques did not imply best comfort,
while torques above 50 N mm reduced
subjective handling comfort. Further, larger
scale studies will be needed to establish that
dialing torque affects pen users’ comfort and
adherence to therapy.
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